MBX Biosciences, Inc. - MBX
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Apr 22, 2026 | — | A | A | 0.0 | 0.0 | 0.0 | 0.0 | View | |
| Apr 22, 2026 | — | A | A | 33,751.0 | 0.0 | 0.0 | 33,751.0 | View | |
| Mar 16, 2026 | President & CEO | P | A | 18,500.0 | 28.4142 | 525,662.7 | 486,777.0 | View | |
| Feb 27, 2026 | President & CEO | M | D | 28,768.0 | 0.0 | 0.0 | 91,668.0 | View | |
| Feb 27, 2026 | President & CEO | M | A | 28,768.0 | 16.0 | 460,288.0 | 728,274.0 | View | |
| Feb 03, 2026 | Chief Financial Officer | A | A | 70,000.0 | 0.0 | 0.0 | 70,000.0 | View | |
| Feb 03, 2026 | Chief Financial Officer | A | A | 15,000.0 | 0.0 | 0.0 | 15,000.0 | View | |
| Feb 03, 2026 | Chief Medical Officer | A | A | 70,000.0 | 0.0 | 0.0 | 70,000.0 | View | |
| Feb 03, 2026 | Chief Medical Officer | A | A | 15,000.0 | 0.0 | 0.0 | 15,000.0 | View | |
| Feb 03, 2026 | President & CEO | A | A | 164,500.0 | 0.0 | 0.0 | 164,500.0 | View | |
| Feb 03, 2026 | President & CEO | A | A | 35,250.0 | 0.0 | 0.0 | 699,506.0 | View | |
| Jan 22, 2026 | — | A | A | 32,000.0 | 0.0 | 0.0 | 32,000.0 | View | |
| Nov 25, 2025 | — | A | A | 8,000.0 | 0.0 | 0.0 | 8,000.0 | View | |
| Nov 07, 2025 | — | A | A | 100,000.0 | 0.0 | 0.0 | 100,000.0 | View | |
| Oct 28, 2025 | President & CEO | M | D | 182,859.0 | 0.0 | 0.0 | 129,708.0 | View | |
| Oct 28, 2025 | President & CEO | M | A | 182,859.0 | 3.25 | 594,291.75 | 664,256.0 | View |